Lp(a) is associated with higher atherogenic risk than LDL on a per-particle basis, providing a rationale for potentially targeting elevated levels, researchers said.
The results add to growing enthusiasm for achieving the holy grail of a lipoprotein(a)-specific lowering agent, but whether it will reduce cardiovascular risk remains unknown.
Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.